ARCHIVES

Abraxane Improves Progression-Free Survival Compared to Decarbazine In Stage IV Disease

This article is from The Cancer Letter archive.

Vol. 35 No. 11 | November 30, 2012

Download PDF Visit The Full Archive

Related Articles

Paulette Gray named director of NCI Division of Extramural Activities.

April 22, 2005

SBRT Delivers Higher Overall Survival Rates Compared to Conventional Radiation Therapy

November 30, 2012

Dingell Asks FDA To Explain Failure To Curtail ESA Ads.

June 15, 2007

Patient Advocacy: congress Delivers Symbolism, Not Solution, Visco Says

October 17, 1997

Ovarian Cancer Screening Finds Cancers, But Also Many False Positives, Study Says

November 25, 2005

NCAB Recommends Withdrawal Of CRCC Comprehensive Status

February 13, 1981